1450 related articles for article (PubMed ID: 16796401)
21. Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus.
Berry JD; Jones S; Drebot MA; Andonov A; Sabara M; Yuan XY; Weingartl H; Fernando L; Marszal P; Gren J; Nicolas B; Andonova M; Ranada F; Gubbins MJ; Ball TB; Kitching P; Li Y; Kabani A; Plummer F
J Virol Methods; 2004 Sep; 120(1):87-96. PubMed ID: 15234813
[TBL] [Abstract][Full Text] [Related]
22. Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus.
Sheahan T; Rockx B; Donaldson E; Corti D; Baric R
J Virol; 2008 Sep; 82(17):8721-32. PubMed ID: 18579604
[TBL] [Abstract][Full Text] [Related]
23. A dominant antigenic epitope on SARS-CoV spike protein identified by an avian single-chain variable fragment (scFv)-expressing phage.
Lee YC; Leu SJ; Hung HC; Wu HH; Huang IJ; Hsieh WS; Chiu WT; Hsieh MS; Cheng TF; Yang YY
Vet Immunol Immunopathol; 2007 May; 117(1-2):75-85. PubMed ID: 17360045
[TBL] [Abstract][Full Text] [Related]
24. An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies.
Zhou T; Wang H; Luo D; Rowe T; Wang Z; Hogan RJ; Qiu S; Bunzel RJ; Huang G; Mishra V; Voss TG; Kimberly R; Luo M
J Virol; 2004 Jul; 78(13):7217-26. PubMed ID: 15194798
[TBL] [Abstract][Full Text] [Related]
25. Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats.
Liu RY; Wu LZ; Huang BJ; Huang JL; Zhang YL; Ke ML; Wang JM; Tan WP; Zhang RH; Chen HK; Zeng YX; Huang W
Virus Res; 2005 Sep; 112(1-2):24-31. PubMed ID: 16022898
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV spike proteins expressed by the vaccinia virus Tiantan strain: secreted sq protein induces robust neutralization antibody in mice.
Yan K; Tan W; Wang H; Wang Y; Zhang X; Li Y; Ruan L
Viral Immunol; 2009 Feb; 22(1):57-66. PubMed ID: 19210229
[TBL] [Abstract][Full Text] [Related]
27. Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus.
Tripet B; Kao DJ; Jeffers SA; Holmes KV; Hodges RS
J Struct Biol; 2006 Aug; 155(2):176-94. PubMed ID: 16697221
[TBL] [Abstract][Full Text] [Related]
28. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
Pinto D; Park YJ; Beltramello M; Walls AC; Tortorici MA; Bianchi S; Jaconi S; Culap K; Zatta F; De Marco A; Peter A; Guarino B; Spreafico R; Cameroni E; Case JB; Chen RE; Havenar-Daughton C; Snell G; Telenti A; Virgin HW; Lanzavecchia A; Diamond MS; Fink K; Veesler D; Corti D
Nature; 2020 Jul; 583(7815):290-295. PubMed ID: 32422645
[TBL] [Abstract][Full Text] [Related]
29. Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibody.
Ng OW; Keng CT; Leung CS; Peiris JS; Poon LL; Tan YJ
PLoS One; 2014; 9(7):e102415. PubMed ID: 25019613
[TBL] [Abstract][Full Text] [Related]
30. Antibody-mediated synergy and interference in the neutralization of SARS-CoV at an epitope cluster on the spike protein.
Zhong L; Haynes L; Struble EB; Tamin A; Virata-Theimer ML; Zhang P
Biochem Biophys Res Commun; 2009 Dec; 390(3):1056-60. PubMed ID: 19861118
[TBL] [Abstract][Full Text] [Related]
31. Production of a monoclonal antibody against SARS-CoV spike protein with single intrasplenic immunization of plasmid DNA.
Yu XF; Liang LH; She M; Liao XL; Gu J; Li YH; Han ZC
Immunol Lett; 2005 Sep; 100(2):177-81. PubMed ID: 15893826
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins.
Tripp RA; Haynes LM; Moore D; Anderson B; Tamin A; Harcourt BH; Jones LP; Yilla M; Babcock GJ; Greenough T; Ambrosino DM; Alvarez R; Callaway J; Cavitt S; Kamrud K; Alterson H; Smith J; Harcourt JL; Miao C; Razdan R; Comer JA; Rollin PE; Ksiazek TG; Sanchez A; Rota PA; Bellini WJ; Anderson LJ
J Virol Methods; 2005 Sep; 128(1-2):21-8. PubMed ID: 15885812
[TBL] [Abstract][Full Text] [Related]
33. [Potent neutralization antibody elicited in mice by SARS-associated coronavirus spike protein S1 domain].
Zhang Y; Yang F; Li YH; Li WH; Tu XM; Wei Q; Zhu H; Liu L; Wang H; Qin C; Yuan GY; He W; Wang SH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):258-60. PubMed ID: 15640862
[TBL] [Abstract][Full Text] [Related]
34. Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies.
Zhu Z; Chakraborti S; He Y; Roberts A; Sheahan T; Xiao X; Hensley LE; Prabakaran P; Rockx B; Sidorov IA; Corti D; Vogel L; Feng Y; Kim JO; Wang LF; Baric R; Lanzavecchia A; Curtis KM; Nabel GJ; Subbarao K; Jiang S; Dimitrov DS
Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12123-8. PubMed ID: 17620608
[TBL] [Abstract][Full Text] [Related]
35. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.
Zhang H; Wang G; Li J; Nie Y; Shi X; Lian G; Wang W; Yin X; Zhao Y; Qu X; Ding M; Deng H
J Virol; 2004 Jul; 78(13):6938-45. PubMed ID: 15194770
[TBL] [Abstract][Full Text] [Related]
36. Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV.
Jiang W; Wang J; Jiao S; Gu C; Xu W; Chen B; Wang R; Chen H; Xie Y; Wang A; Li G; Zeng D; Zhang J; Zhang M; Wang S; Wang M; Gui X
MAbs; 2021; 13(1):1953683. PubMed ID: 34313527
[TBL] [Abstract][Full Text] [Related]
37. Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents.
Keng CT; Zhang A; Shen S; Lip KM; Fielding BC; Tan TH; Chou CF; Loh CB; Wang S; Fu J; Yang X; Lim SG; Hong W; Tan YJ
J Virol; 2005 Mar; 79(6):3289-96. PubMed ID: 15731223
[TBL] [Abstract][Full Text] [Related]
38. Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV).
Lai SC; Chong PC; Yeh CT; Liu LS; Jan JT; Chi HY; Liu HW; Chen A; Wang YC
J Biomed Sci; 2005 Oct; 12(5):711-27. PubMed ID: 16132115
[TBL] [Abstract][Full Text] [Related]
39. Antibody binding site mapping of SARS-CoV spike protein receptor-binding domain by a combination of yeast surface display and phage peptide library screening.
Zhang X; Wang J; Wen K; Mou Z; Zou L; Che X; Ni B; Wu Y
Viral Immunol; 2009 Dec; 22(6):407-15. PubMed ID: 19951177
[TBL] [Abstract][Full Text] [Related]
40. Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain.
Yi CE; Ba L; Zhang L; Ho DD; Chen Z
J Virol; 2005 Sep; 79(18):11638-46. PubMed ID: 16140741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
